Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01412931 · ClinicalTrials.gov registry record
Protein and Ultrasound Indicators of Preterm Birth
A clinical trial of Preterm Birth, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 3
- Enrollment target
- 1
- Study location
NCT01412931: Completed study of Preterm Birth, sponsored by University of Colorado, Denver.
NCT01412931 is a study of Preterm Birth that has completed, run by University of Colorado, Denver. The registered enrollment target is 3 participants, below the 4,409-participant average among 39 other Preterm Birth trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01412931, a study of Preterm Birth, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
Women are being asked to participate in a research study that is looking for new methods to understand and predict premature birth (birth before 37 weeks of pregnancy-full term pregnancy is 40 weeks). In this study the investigators will be looking at proteins in vaginal fluid, tissue from the placenta after the baby is born (fetal membranes), and a new form of ultrasound of the mouth of the womb (cervix) that measures its length, volume, and stiffness, in order to try to know who will have a preterm birth and who will reach full term. The investigators will collect the vaginal fluid samples and perform ultrasounds both in the clinic throughout pregnancy in normal women, and from women admitted to the hospital because they are in early labor. The investigators will collect the placental tissue after the baby is born (this is normally discarded). This study will help us to understand the process of preterm birth and the investigators hope that this will eventually allow us to develop better methods to treat preterm labor and prevent the birth of premature babies.
Primary Outcome
Serial elastography measurements will enable us to quantify changes in tissue modulus and structure longitudinally through normal, term pregnancy.
Conditions Studied
Study Locations (1)
Colorado
- University of Colorado Hospital - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-12 |
What the finished NCT01412931 record still lists
NCT01412931 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 4,409-participant average among 39 other Preterm Birth trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Preterm Birth appearing as the primary indexed condition, and to 0 interventions.
NCT01412931 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT01412931 about?
NCT01412931 is a clinical study titled "Protein and Ultrasound Indicators of Preterm Birth". Women are being asked to participate in a research study that is looking for new methods to understand and predict premature birth (birth before 37 weeks of pregnancy-full term pregnancy is 40 weeks). In this study the investigators will be looking at proteins in vaginal fluid, tissue from the place...
What is the current status of trial NCT01412931?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2011-09. Estimated completion is 2013-12.
What conditions does trial NCT01412931 study?
This clinical trial studies the following conditions: Preterm Birth.
Who is sponsoring clinical trial NCT01412931?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01412931 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preterm Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01412931's enrollment target sits among peer trials
3 40th of 39 the lowest of 39 other Preterm Birth trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preterm Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transition From Donor Milk: a Feasibility Study
RECRUITING · NA
-
Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)
RECRUITING · Phase 4
-
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
RECRUITING · NA
-
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
RECRUITING · Phase 1
-
Stress Phenotypes and Preterm Birth
RECRUITING · NA
-
The Effect of Sulfasalazine on CRH Levels in Pregnant Women
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia